Page 9 - Condensed Statement News Today

Press release content from Accesswire. The AP news staff was not involved in its creation. Helix BioPharma Corp. Announces Fiscal Second Quarter 2021 Results March 16, 2021 GMT RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX:"HBP"), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second ... RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TS...

Share this article Share this article SANDUSKY, Ohio, Feb. 5, 2021 /PRNewswire/ -- Civista Bancshares, Inc. (NASDAQ:CIVB) ("Civista") announced its unaudited financial results for the three and twelve months ending December 31, 2020.  Fourth quarter and year-to-date 2020 highlights Earned net income of $10.2 million, or $0.64 per diluted share, for the fourth quarter of 2020, compared to $7.7 million, or $0.47 per diluted share, for the fourth quarter of 2019.  Earned net income for the ye...

  Operating revenues in 4Q20 slightly increased to NT$45.30 billion. Revenue contribution from 40nm and below technologies increased to 40%. Gross profit grew 11.0% QoQ to NT$10.85 billion, or 23.9% of revenue. Operating expenses increased 15.0% to NT$6.34 billion. Net other operating income declined to NT$1.10 billion. Net non-operating income was NT$5.62 billion. Net income attributable to stockholders of the parent grew 22.9% QoQ to NT$11.20 billion. Earnings per ordinary share for the quar...

Harrogate Group Plc - Interim Results; 1st April to 30th Sept 2020 PR Newswire London, January 8 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY HARROGATE GROUP PLC TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED ("MAR"). ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE ("RIS"), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. HARROGATE GROUP PLC RESULTS FOR THE PERIOD...

  Results and Dividends As shareholders will be well aware, this has been an extraordinary six months, as the world battled the pandemic spread of the COVID-19 virus. After initially imposing draconian restrictions on movement, governments are gradually relaxing social-distancing measures and,  supported by unprecedented monetary and fiscal stimulus, a global economic recovery appears to be underway. Asian markets were surprisingly positive against such a challenging backdrop, with the benchm...

  1 - The earnings per share of £3.44 relates to the six month period from 1 April 2020 to 30 September 2020 whereas loss per share of (£0.60) relates to the financial year from 1 April 2019 to 31 March 2020.     I am pleased to report another excellent set of results for the period ended 30 September 2020. As was prefaced in the Chairmans statement accompanying the Annual Report, we had seen a substantial recovery from the lows of March, I am theref...